TickerFactsScreenerDevelopers

Alzamend Neuro, Inc. (ALZN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $42.6K2020: $90.3K2021: $1.93M2022: $14.06M2023: $5.14M2024: $376.0K2025: $3.95M2026: $710.7K$710.7K
2019Cash & Equivalents (USD)2026
Fiscal YearCash & EquivalentsChange YoY
2026$710.7K-82.0%
2025$3.95M+950.0%
2024$376.0K-92.7%
2023$5.14M-63.4%
2022$14.06M+629.0%
2021$1.93M+2036.9%
2020$90.3K+111.9%
2019$42.6K—